Liraglutide, a GLP-1 receptor agonist, attenuates isoprenaline-induced acute myocardila injury via inhibition of the Wnt/β-catenin signalling pathway.

Naslov

Liraglutide, a GLP-1 receptor agonist, attenuates isoprenaline-induced acute myocardila injury via inhibition of the Wnt/β-catenin signalling pathway.

Identifikator

/unibl/sci/idNaucniRad:34737

Tip

Datum

Bibliografski citat

R. Škrbić, Z. Bajić, LJ. Amidžić, N. Vojinović, M. Barudžija, T. Šobot, M. Gajić Bojić, T. Cvjetković, U. Maličević, A. Krivokuća, Đ. Đukanović, S. Uletilović, M. Stojiljković, Liraglutide, a GLP-1 receptor agonist, attenuates isoprenaline-induced acute myocardila injury via inhibition of the Wnt/β-catenin signalling pathway., Oct, 2023

Prezentovano

9. skup Evropske sekcije Internacionalne akademije za kardiovaskularne nauke

Lista autora

Position: 122159 (14 views)